GMA Medical Research

Patient receiving IV treatment -1200 - Maggie Perkins 2017

Gordon Medical has been actively doing research into Chronic Fatigue Syndrome (CFS/ME), Multiple Chemical Sensitivity (MCS), and chronic Lyme Disease since 2005. We are now also partnering with researchers at Stanford University, along with several groups working to improve collecting and processing patient history and outcome data. In 2014 we established Science in Service of Humanity to be our research arm, and in 2016 we founded the Gordon Medical Research Center, a non-profit fundraising corporation that would allow tax deductible donations to support our research.

Our Metabolomics study on Chronic Fatigue Syndrome was published August 2016 in the Proceedings of the National Academay of Sciences (PNAS), one of the most prestigious medical journals in the US and the world. This ground breaking study is changing the way chronic illness, and Chronic Fatigue Syndrome in particular will be understood and treated.

Chronic fatigue syndrome is a multisystem disease that causes long-term pain and disability. It is difficult to diagnose because of its protean symptoms and the lack of a diagnostic laboratory test. We report that targeted, broad-spectrum metabolomics of plasma not only revealed a characteristic chemical signature but also revealed an unexpected underlying biology. Metabolomics showed that chronic fatigue syndrome is a highly concerted hypometabolic response to environmental stress that traces to mitochondria and was similar to the classically studied developmental state of dauer. This discovery opens a fresh path for the rational development of new therapeutics and identifies metabolomics as a powerful tool to identify the chemical differences that contribute to health and disease.

Read the full study

Metabolomics Q&A for CFS v6

See the Team at GMRC

Gordon Medical Research Center

Funding Research Into Poorly Understood Chronic Illness

The opening of the Gordon Medical Research Center is a critical element in developing funding for the research into the complex illnesses we focus on. Your donation will make possible further research into metabolomics and mitochondrial function and their impact on health and illness. Illnesses potentially caused by mitochondrial dysfunction will ultimately affect over 50% of the people born today. These diseases include autoimmune diseases, autism, Myalgic Encephalopathy/Chronic Fatigue Syndrome (ME/CFS), Post-Traumatic Stress Disorder (PTSD), Gulf War Illness, diabetes, heart disease, certain mental health disorders, and cancer.

See the Team at SISOH

Science in Service of Humanity

Science in Service of Humanity (SISOH) is a research organization focused on poorly understood and defined illness such as CFS/ME, chronic Lyme Disease, Fibromyalgia, Autism, and Multiple Chemical Sensitivity.

We have been involved in the Metabolomics research that resulted in the published paper, “Metabolic features of chronic fatigue syndrome“. We are continuing our reserach into metablomics in the new study, Analyzing Individual Metabolomics Study (AIMS). You can find out more about the research, and sign up to participate on the SISOH website.

Stay Up To Date On Our Research News

RSS Unknown Feed

  • An error has occurred, which probably means the feed is down. Try again later.
What They Are Saying About
Metabolic features of chronic fatigue syndrome
Science in Service of Humanity logo

Metabolic features of chronic fatigue syndrome - Scientists find signature of Chronic Fatigue Syndrome in blood which suggests disease is the body going into hibernation. New research has revealed a chemical signature of the disease in the blood of those with ME. Scientists from the University of California claim it is similar to a state found in nematode worms called dauer, where the metabolism adjusts to a difficult environment by slowing down. This hibernation state enables existence, but not much more.

Telegraph News Read full article
Science in Service of Humanity logo

Metabolic features of chronic fatigue syndrome - This landmark ME/CFS research is the most important and groundbreaking study of ME/CFS to date. Extending recent indications of metabolic alterations in ME/CFS, this study provides the first comprehensive, quantitative demonstration of the metabolomic deficiencies that characterize the disease. They define a clear metabolic ‘signature’ that accurately distinguishes patients from healthy individuals. These findings are exciting news for both patients and researchers.

Ron Davis - Director of Stanford Chronic Fatigue Syndrome Research Read Full Article